Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 35, Issue -, Pages S93-S98Publisher
SPRINGER
DOI: 10.1007/s00259-007-0708-7
Keywords
Optical probes; Fluorescence imaging; Alzheimer's disease; Near-infrared
Funding
- NIH [EB00768, AG026240]
- US Army through the Institute for Soldier Nanotechnologies [DAAD-19-02-D-0002]
- NDSEG fellowship
- Harvard University Ashford fellowship
- [T32 EB001680]
Ask authors/readers for more resources
Purpose Near-infrared fluorescent probes for amyloid-beta (A beta) are an exciting option for molecular imaging in Alzheimer's disease research and may translate to clinical diagnostics. However, A beta-targeted optical probes often suffer from poor specificity and slow clearance from the brain. We are designing smart optical probes that emit characteristic fluorescence signal only when bound to A beta. Methods We synthesized a family of dyes and tested A beta-binding sensitivity with fluorescence spectroscopy and tissue-staining. Results Select compounds exhibited A beta-dependent changes in fluorescence quantum yield, lifetime, and emission spectra that may be imaged microscopically or in vivo using new lifetime and spectral fluorescence imaging techniques. Conclusion Smart optical probes that turn on when bound to A beta will improve amyloid detection and may enable quantitative molecular imaging in vivo.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available